Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combination versus sequential cytotoxic chemotherapy in recurrent ovarian cancer: time for an evidence-based comparison.

× No keyword cloud information.

5 in total

1. Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin.

Authors: Cheryl A Sherman-Baust; Kevin G Becker; William H Wood Iii; Yongqing Zhang; Patrice J Morin
Journal: J Ovarian Res Date: 2011-12-05 Impact factor: 4.234

2. Molecular genetics complexity impeding research progress in breast and ovarian cancers.

Authors: Ishita Gupta; Ikram Burney; Mansour S Al-Moundhri; Yahya Tamimi
Journal: Mol Clin Oncol Date: 2017-05-29

3. Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines.

Authors: Nada Abdullah; Najwa Al Balushi; Syed I Hasan; Shadia Al Bahlani; Sergey Dobretsov; Yahya Tamimi; Ikram A Burney
Journal: Sultan Qaboos Univ Med J Date: 2021-11-25

4. Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis.

Authors: Nada Abdullah; Yahya Tamimi; Sergey Dobretsov; Najwa Al Balushi; Jalila Alshekaili; Hamed Al Balushi; Mahmood Al Kindi; Syed Imran Hassan; Shadia Al Bahlani; Benjamin K Tsang; Ikram A Burney
Journal: Molecules Date: 2021-06-13 Impact factor: 4.411

5. ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.

Authors: Matthew J Schultz; Amanda F Swindall; John W Wright; Elizabeth S Sztul; Charles N Landen; Susan L Bellis
Journal: J Ovarian Res Date: 2013-04-11 Impact factor: 4.234

5 in total